What is the GDF?
The GDF is not a traditional procurement mechanism. It has adopted a new perspective on TB drug procurement, by linking demand for drugs to supply and monitoring, using product packaging to simplify drug management and linking grants to TB programme performance. The GDF provides a unique package of services, including technical assistance in TB drug management and monitoring of TB drug use, as well as procurement of high-quality TB drugs at low cost.
Established in 2001, to expand access to and availability of, high-quality TB drugs to facilitate DOTS expansion, the GDF is one of the most important initiatives of the Stop TB Partnership.
It was created in response to difficulties experienced by countries in the 1990s in finding and funding stable high-quality TB drug supplies. This in turn hindered the expansion of the DOTS TB control strategy. Perhaps of even greater concern, is that patients develop resistance to TB drugs as a result of poor quality drugs and unreliable supply channels making the disease difficult and expensive to treat.
Ten years later, GDF operates a unique pool procurement system responding to the main barriers to quality-assured TB drug access with:
- Low prices: Competitive prices of between US$ 14 -18 for a six month course of first-line TB treatment for an average weight patient with the final price depending on the treatment regimen used and the packaging of the tablets
- Quality Control: High-quality products which meet WHO's stringent standards
- Standardization: Individual patient blister packs for easy administration
- Pool procurement: Rapid drug delivery times
- Transparency: Web-based tracking of orders
- Procurement & Supply management: In-country technical support on drug management, registration and supply issues
The GDF also developed an application process that is simple and quick. Both governments and non-governmental organizations (NGOs) in collaboration with the respective Ministries of Health are able to apply for GDF assistance. Countries simply complete an application that includes information on TB drug needs, the national TB programme's strategy and a description of the procurement and supply chain management.
By December 2010, the GDF had supplied first-line TB drugs to more than 90 countries, including to 18 of the 22 high TB burden ones, translating into a cumulative supply of more than 18 million patient treatments.
As a result of its success the GDF mechanism is being seen as a possible model for cheap and effective drug delivery in the fight against HIV/AIDS and malaria.
We aim to:
- Save 25 million lives and prevent 50 million new TB cases by 2020
- Prevent new strains of drug-resistant TB emerging
- Make purchasing TB drugs more cost-effective
- Improve the quality of TB drugs globally
Latest GDF brochures
GDF is ISO 9001:2000 compliant for provision of quality-assured anti-TB drugs and related services to eligible national TB control programmes.